Evidence map›Paper›PMID 39292175›Full record

ArticleJournal of diabetes investigation2024

Problems in screening for gestational diabetes mellitus by measurement of casual blood glucose levels at 24-28 gestational weeks.

Masako Tomimoto, Kenji Tanimura, Naohisa Masuko, Akiko Uchida, Hitomi Imafuku, Masashi Deguchi, Akane Yamamoto, Yushi Hirota, Wataru Ogawa, Yoshito Terai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masako TomimotoDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Kenji TanimuraDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0003-1435-120X
Naohisa MasukoDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Akiko UchidaDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Hitomi ImafukuDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Masashi DeguchiDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.
Akane YamamotoDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Yushi HirotaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0002-3035-4155
Wataru OgawaDivision of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.ORCID https://orcid.org/0000-0002-0432-4366
Yoshito TeraiDepartment of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

AIMS/

introductionThis study aimed to evaluate the problems in screening for gestational diabetes mellitus (GDM) by casual blood glucose (CBG) measurements at 24-28 gestational weeks. MATERIALS AND

methodsOverall, 763 pregnant women who underwent the 50-g glucose challenge test (GCT) at 24-28 gestational weeks were enrolled. The preload blood glucose (0-h BG) level of 50-g GCT was considered as CBG.

resultsA total of 240 women with BG levels at 1-h after loading (1-h BG) on 50-g GCT ≥140 mg/dL underwent the 75-g oral glucose tolerance test, and 98 (40.8%) were diagnosed with GDM. Of the 99 women with GDM, 71 (71.7%) had 0-h BG on 50-g GCT <100 mg/dL.

conclusionsThis study, where pregnant women underwent both CBG and 50-g GCT simultaneously, showed that when CBG at 24-28 gestational weeks ≥100 mg/dL alone was used for screening GDM, many pregnant women with GDM were overlooked.

Indexed as

Blood GlucoseDiabetes, GestationalGlucose Tolerance TestAdultFemaleGestational AgeHumansMass ScreeningPregnancyPregnancy Trimester, SecondBlood Glucose50‐g oral glucose challenge testCasual blood glucoseGestational diabetes mellitus

Identifiers

PMID39292175
PMCPMC11615677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.